The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
about
Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesHepatitis B virus reactivation with rituximab-containing regimenPrevention of hepatitis B virus reactivation under rituximab therapy.Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapyRituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsHepatitis B reactivation and rituximab in the oncology practice.Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.The late adverse events of rituximab therapy--rare but there!Management of rheumatic disease with comorbid HBV or HCV infection.A drug safety evaluation of rituximab and risk of hepatitis B.Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab.Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.Hepatitis B reactivation and rituximab: a new boxed warning and considerations for solid organ transplantation.Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies.Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.
P2860
Q26746486-9B16635C-4FA0-4A7D-B47F-DE07263BCADFQ26830484-17EB2993-BA38-455B-953A-522EA02D66DCQ33390799-06228BBF-4917-49E1-9094-05B794CED0FBQ33935351-C5ADCE99-E970-4325-AB6F-3DAD596A23EBQ34828556-2AFE0115-76E1-4565-9709-DC9EC0F06100Q34854165-098FA875-3C5A-4959-B0B6-FE49374F9F86Q35583718-2DC0B388-284C-473D-8E6D-C2C7DF718524Q35963027-074736B2-A917-4DC6-8628-126B3D24D960Q37462485-0F8BC52B-1764-436D-96D5-FF707F6C13FFQ38008173-E91379D6-ED9B-49FA-A9C4-ED25CD178914Q38211373-10903907-0FA1-4217-BD1A-47B9E8A9159AQ38218566-D1E38DA4-2CF7-4093-B106-819005D75126Q38253568-CC50BE63-97EE-40C1-B6E4-ECD08B7AED0AQ42145809-92F511FD-FDD8-44D5-945D-8CB09EE5A1FFQ42173132-4365192D-4574-4AAD-8FA0-3764E41695D1Q42203535-DC7AC6BC-3048-46D4-9164-8DBBD568E558Q42233865-8B7A2292-4830-4C20-B60B-105F0B4386EAQ42952349-C19C20D0-B559-4FBA-84C6-14AF36D20622Q45353928-87CB6A65-6AF6-449A-A46F-0263F06490B1Q45366697-66B615C9-BD1A-4A66-BCEC-1674E0BB2F68Q51841676-0D3154C9-DD42-4AE6-AC0F-6D3E94EB74A0
P2860
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The effectiveness of lamivudin ...... ntaining regimen for lymphoma.
@en
The effectiveness of lamivudin ...... ntaining regimen for lymphoma.
@nl
type
label
The effectiveness of lamivudin ...... ntaining regimen for lymphoma.
@en
The effectiveness of lamivudin ...... ntaining regimen for lymphoma.
@nl
prefLabel
The effectiveness of lamivudin ...... ntaining regimen for lymphoma.
@en
The effectiveness of lamivudin ...... ntaining regimen for lymphoma.
@nl
P2093
P1433
P1476
The effectiveness of lamivudin ...... ontaining regimen for lymphoma
@en
P2093
Feng-Hua Wang
Hui-Qiang Huang
Shi-Ping Bao
Tong-Yu Lin
Wen-Qi Jiang
Xiao-Fei Sun
You-Jian He
Yu-Hong Li
P304
P356
10.1007/S00277-008-0454-3
P50
P577
2008-02-26T00:00:00Z